Pre-infusion biomarkers for forecasting #CRS & #ICANS in children after #CAR-T treatment #PediatricOncology #Immunotherapy aacrjournals.org/clincancerres/…

Impostor syndrome isn't a disease. It's a normal response to internalizing impossibly high standards. Doubting yourself doesn't mean you're going to fail. It usually means you're facing a new challenge and you're going to learn. Feeling uncertainty is a precursor to growth.

So far 4 cancers have occurred in #hemophilia patients who have undergone gene therapy with AAV vectors. Salivary gland cancer and ALL in the Biomarin trial, Hepatocellular Carcinoma in the UniQure trial and Tonsil cancer in a Baxter trial. 1/3

An intercellular transfer of telomeres rescues T cells from senescence and promotes long-term immunological memory 🤯 nature.com/articles/s4155…

How to manage donor-specific antibodies in children receiving a #BMTsm? 🤔 Wonder no more 👉 former St. Jude Research fellow and current Sarah Cannon Docs #PHOdoc Amanda Lipsitt MD described what to do to prepare patients for a transplant #desensitization American Society of Pediatric Hematology/Oncology onlinelibrary.wiley.com/doi/10.1002/pb…

While growing up in the Alamo City, Dr. Amanda Lipsitt seemed destined for a life in medicine. She attended Health Careers and enjoyed visiting hospitals with her pediatrician father. Fast forward and now we get to welcome her to our team! Learn more: methodistphysicianpractices.com/physicians/pro…

Looking forward to working with this amazing team! 😊 Sarah Cannon Docs Methodist Physicians @BldCancerDoc Paul Shaughnessy CBachier Haydar Frangoul

Surround yourself with positive people. Also, be a positive person. Root for people. Somebody else's success is not your failure.

Doctors don’t vote. We say we do… but voting is public record and data tells a different story. I don’t have time to judge anyone, so here are some solutions instead. What can we do about it today. 🧵

Writing a great abstract can be tricky! This writing template by nature is super helpful 👉

Check out an interesting case I had when I was a fellow at St. Jude that I presented last summer at Colleen Allen transplant course! Thank you The EBMT Trainee Committee for asking me to participate in one of your twitter cases 😊

It's moments like these that define us. We certainly have the choice to sulk. But we also have the power to act.

N-Acetylcysteine as Prophylactic Therapy for Transplantation-Associated Thrombotic Microangiopathy: A Randomized, Placebo-Controlled Trial astctjournal.org/article/S2666-…

Proud to work with Nirali Shah on the ASTCT cell therapy committee. In addition to her many contributions to breakthrough trials in children, she has led efforts to describe CAR-T toxicities, including #tcellrx hemophagocyctic syndromes (now termed IEC-HS). #immunotherapy

Excited to be at the first day of Tandem with these awesome colleagues! #Tandem23 ASTCT Paul Shaughnessy CBachier Sarah Cannon Docs

The end to a great #tandem23 conference…learned a ton, presented a couple posters, and connected with friends old and new. Can’t wait to see everyone next year in my home city of San Antonio! #tandem24 Paul Shaughnessy @BldCancerDoc Lauren Appell ASTCT

A medical breakthrough for patients, FK-506 was a more effective and potent immunosuppressant than what had been used previously. Dr. Starzl and his team of researchers were instrumental in its development and in providing support for its widespread use.

In our latest publication in @BloodJournal, Cara Morin, MD, PhD and I report an increase in myocardial extracellular volume (ECV) in patients with #SickleCell disease despite early intervention with disease-modifying therapies ☹️ sciencedirect.com/science/articl…

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma is feasible and improves survival #BMTsm #Immunotherapy ascopubs.org/doi/10.1200/JC…